Copyright Reports & Markets. All rights reserved.

Global Budesonide Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Budesonide Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Injectable Suspension
    • 1.3.3 Aerosols
    • 1.3.4 Inhalation Powder
    • 1.3.5 Tablet and Capsule
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Budesonide Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Respiratory Disease Treatment
    • 1.4.3 Nose Disease Treatment
    • 1.4.4 Inflammatory Bowel Disease Treatment
    • 1.4.5 Others
  • 1.5 Global Budesonide Market Size & Forecast
    • 1.5.1 Global Budesonide Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Budesonide Sales Quantity (2020-2031)
    • 1.5.3 Global Budesonide Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 AstraZeneca
    • 2.1.1 AstraZeneca Details
    • 2.1.2 AstraZeneca Major Business
    • 2.1.3 AstraZeneca Budesonide Product and Services
    • 2.1.4 AstraZeneca Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 AstraZeneca Recent Developments/Updates
  • 2.2 Teva
    • 2.2.1 Teva Details
    • 2.2.2 Teva Major Business
    • 2.2.3 Teva Budesonide Product and Services
    • 2.2.4 Teva Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Teva Recent Developments/Updates
  • 2.3 Mylan
    • 2.3.1 Mylan Details
    • 2.3.2 Mylan Major Business
    • 2.3.3 Mylan Budesonide Product and Services
    • 2.3.4 Mylan Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Mylan Recent Developments/Updates
  • 2.4 Sandoz
    • 2.4.1 Sandoz Details
    • 2.4.2 Sandoz Major Business
    • 2.4.3 Sandoz Budesonide Product and Services
    • 2.4.4 Sandoz Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Sandoz Recent Developments/Updates
  • 2.5 Cosmo Pharmaceuticals
    • 2.5.1 Cosmo Pharmaceuticals Details
    • 2.5.2 Cosmo Pharmaceuticals Major Business
    • 2.5.3 Cosmo Pharmaceuticals Budesonide Product and Services
    • 2.5.4 Cosmo Pharmaceuticals Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Cosmo Pharmaceuticals Recent Developments/Updates
  • 2.6 Salix
    • 2.6.1 Salix Details
    • 2.6.2 Salix Major Business
    • 2.6.3 Salix Budesonide Product and Services
    • 2.6.4 Salix Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Salix Recent Developments/Updates
  • 2.7 Chiesi Farmaceutici
    • 2.7.1 Chiesi Farmaceutici Details
    • 2.7.2 Chiesi Farmaceutici Major Business
    • 2.7.3 Chiesi Farmaceutici Budesonide Product and Services
    • 2.7.4 Chiesi Farmaceutici Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Chiesi Farmaceutici Recent Developments/Updates
  • 2.8 Orion Corporation
    • 2.8.1 Orion Corporation Details
    • 2.8.2 Orion Corporation Major Business
    • 2.8.3 Orion Corporation Budesonide Product and Services
    • 2.8.4 Orion Corporation Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Orion Corporation Recent Developments/Updates
  • 2.9 Cipla
    • 2.9.1 Cipla Details
    • 2.9.2 Cipla Major Business
    • 2.9.3 Cipla Budesonide Product and Services
    • 2.9.4 Cipla Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Cipla Recent Developments/Updates
  • 2.10 Synmosa Biopharma
    • 2.10.1 Synmosa Biopharma Details
    • 2.10.2 Synmosa Biopharma Major Business
    • 2.10.3 Synmosa Biopharma Budesonide Product and Services
    • 2.10.4 Synmosa Biopharma Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Synmosa Biopharma Recent Developments/Updates
  • 2.11 Lunan Better Pharma
    • 2.11.1 Lunan Better Pharma Details
    • 2.11.2 Lunan Better Pharma Major Business
    • 2.11.3 Lunan Better Pharma Budesonide Product and Services
    • 2.11.4 Lunan Better Pharma Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Lunan Better Pharma Recent Developments/Updates
  • 2.12 Shanghai Sine Promod
    • 2.12.1 Shanghai Sine Promod Details
    • 2.12.2 Shanghai Sine Promod Major Business
    • 2.12.3 Shanghai Sine Promod Budesonide Product and Services
    • 2.12.4 Shanghai Sine Promod Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Shanghai Sine Promod Recent Developments/Updates

3 Competitive Environment: Budesonide by Manufacturer

  • 3.1 Global Budesonide Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Budesonide Revenue by Manufacturer (2020-2025)
  • 3.3 Global Budesonide Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Budesonide by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Budesonide Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Budesonide Manufacturer Market Share in 2024
  • 3.5 Budesonide Market: Overall Company Footprint Analysis
    • 3.5.1 Budesonide Market: Region Footprint
    • 3.5.2 Budesonide Market: Company Product Type Footprint
    • 3.5.3 Budesonide Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Budesonide Market Size by Region
    • 4.1.1 Global Budesonide Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Budesonide Consumption Value by Region (2020-2031)
    • 4.1.3 Global Budesonide Average Price by Region (2020-2031)
  • 4.2 North America Budesonide Consumption Value (2020-2031)
  • 4.3 Europe Budesonide Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Budesonide Consumption Value (2020-2031)
  • 4.5 South America Budesonide Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Budesonide Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Budesonide Sales Quantity by Type (2020-2031)
  • 5.2 Global Budesonide Consumption Value by Type (2020-2031)
  • 5.3 Global Budesonide Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Budesonide Sales Quantity by Application (2020-2031)
  • 6.2 Global Budesonide Consumption Value by Application (2020-2031)
  • 6.3 Global Budesonide Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Budesonide Sales Quantity by Type (2020-2031)
  • 7.2 North America Budesonide Sales Quantity by Application (2020-2031)
  • 7.3 North America Budesonide Market Size by Country
    • 7.3.1 North America Budesonide Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Budesonide Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Budesonide Sales Quantity by Type (2020-2031)
  • 8.2 Europe Budesonide Sales Quantity by Application (2020-2031)
  • 8.3 Europe Budesonide Market Size by Country
    • 8.3.1 Europe Budesonide Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Budesonide Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Budesonide Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Budesonide Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Budesonide Market Size by Region
    • 9.3.1 Asia-Pacific Budesonide Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Budesonide Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Budesonide Sales Quantity by Type (2020-2031)
  • 10.2 South America Budesonide Sales Quantity by Application (2020-2031)
  • 10.3 South America Budesonide Market Size by Country
    • 10.3.1 South America Budesonide Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Budesonide Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Budesonide Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Budesonide Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Budesonide Market Size by Country
    • 11.3.1 Middle East & Africa Budesonide Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Budesonide Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Budesonide Market Drivers
  • 12.2 Budesonide Market Restraints
  • 12.3 Budesonide Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Budesonide and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Budesonide
  • 13.3 Budesonide Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Budesonide Typical Distributors
  • 14.3 Budesonide Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Budesonide market size was valued at US$ 8985 million in 2024 and is forecast to a readjusted size of USD 11120 million by 2031 with a CAGR of 3.1% during review period.
    Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn"s disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
    North America is the largest market with about 36% revenue market share. Followed by Asia-Pacific and Europe, accounting for about 60% revenue market share.
    The key players are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod etc. AstraZeneca is the largest manufacturer with about 56% revenue market share.
    This report is a detailed and comprehensive analysis for global Budesonide market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Budesonide market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/K Units), 2020-2031
    Global Budesonide market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/K Units), 2020-2031
    Global Budesonide market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/K Units), 2020-2031
    Global Budesonide market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (USD/K Units), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Budesonide
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Budesonide market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Budesonide market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Injectable Suspension
    Aerosols
    Inhalation Powder
    Tablet and Capsule
    Market segment by Application
    Respiratory Disease Treatment
    Nose Disease Treatment
    Inflammatory Bowel Disease Treatment
    Others
    Major players covered
    AstraZeneca
    Teva
    Mylan
    Sandoz
    Cosmo Pharmaceuticals
    Salix
    Chiesi Farmaceutici
    Orion Corporation
    Cipla
    Synmosa Biopharma
    Lunan Better Pharma
    Shanghai Sine Promod
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Budesonide product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Budesonide, with price, sales quantity, revenue, and global market share of Budesonide from 2020 to 2025.
    Chapter 3, the Budesonide competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Budesonide breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Budesonide market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Budesonide.
    Chapter 14 and 15, to describe Budesonide sales channel, distributors, customers, research findings and conclusion.

    Buy now